Jennifer A Pruskowski1, Sydney Springer2,3,4, Carolyn T Thorpe3,5, Michele Klein-Fedyshin6, Steven M Handler7. 1. School of Pharmacy, University of Pittsburgh, 3600 Forbes Avenue at Meyran Avenue, Suite 308.15, Pittsburgh, PA, 15213, USA. pruskowskija@upmc.edu. 2. School of Pharmacy, University of Pittsburgh, 3600 Forbes Avenue at Meyran Avenue, Suite 308.15, Pittsburgh, PA, 15213, USA. 3. Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, USA. 4. College of Pharmacy, University of New England, Portland, ME, USA. 5. Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. 6. Library System, University of Pittsburgh Health Sciences, Pittsburgh, PA, USA. 7. School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Abstract
BACKGROUND: Deprescribing has been shown to reduce potentially inappropriate or unnecessary medications; however, whether these benefits translate into improved quality of life (QOL) is uncertain. OBJECTIVE: The objective of this study was to isolate the impact of deprescribing on patient or designated representative reported QOL; satisfaction with care (SWC) and emergency department (ED) visits and hospitalizations were also investigated to further explore this question. METHODS: This systematic review searched the Cochrane Library, Cumulative Index to Nursing and Allied Health (CINAHL), MEDLINE, and EMBASE from database inception until November 2017. Randomized controlled trials and non-randomized prospective studies of older adults (> 65 years or older) and older persons with life-limiting conditions were included. Two reviewers independently assessed the search results and performed risk of bias assessments. Data on QOL, SWC, and ED visits and hospitalizations were extracted from all identified studies. Risk of bias of individual studies was assessed using measures recommended by the Cochrane Collaboration. RESULTS: Screening of 6543 eligible records identified 12 studies within 13 articles. In ten studies investigating the reduction of at least one medication deprescribed, compared with usual care, all but two found no difference in QOL. To date there has only been one study examining the impact of deprescribing on SWC, which was found to be not statistically significant. Four studies exploring the impact of deprescribing on ED visits and hospitalizations also found no significant difference. However, many studies were found to have a higher performance, detection, or other bias. We found considerable heterogeneity in patient populations, targeted medications for deprescribing, and QOL measurements used in these studies. CONCLUSION: Based on a limited number of studies with varying methodological rigor, deprescribing may not significantly improve QOL or SWC; however, it may not contribute to additional ED visits and hospitalizations. Future controlled studies are needed.
BACKGROUND: Deprescribing has been shown to reduce potentially inappropriate or unnecessary medications; however, whether these benefits translate into improved quality of life (QOL) is uncertain. OBJECTIVE: The objective of this study was to isolate the impact of deprescribing on patient or designated representative reported QOL; satisfaction with care (SWC) and emergency department (ED) visits and hospitalizations were also investigated to further explore this question. METHODS: This systematic review searched the Cochrane Library, Cumulative Index to Nursing and Allied Health (CINAHL), MEDLINE, and EMBASE from database inception until November 2017. Randomized controlled trials and non-randomized prospective studies of older adults (> 65 years or older) and older persons with life-limiting conditions were included. Two reviewers independently assessed the search results and performed risk of bias assessments. Data on QOL, SWC, and ED visits and hospitalizations were extracted from all identified studies. Risk of bias of individual studies was assessed using measures recommended by the Cochrane Collaboration. RESULTS: Screening of 6543 eligible records identified 12 studies within 13 articles. In ten studies investigating the reduction of at least one medication deprescribed, compared with usual care, all but two found no difference in QOL. To date there has only been one study examining the impact of deprescribing on SWC, which was found to be not statistically significant. Four studies exploring the impact of deprescribing on ED visits and hospitalizations also found no significant difference. However, many studies were found to have a higher performance, detection, or other bias. We found considerable heterogeneity in patient populations, targeted medications for deprescribing, and QOL measurements used in these studies. CONCLUSION: Based on a limited number of studies with varying methodological rigor, deprescribing may not significantly improve QOL or SWC; however, it may not contribute to additional ED visits and hospitalizations. Future controlled studies are needed.
Authors: Stephanie L Harrison; Lisa Kouladjian O'Donnell; Clare E Bradley; Rachel Milte; Suzanne M Dyer; Emmanuel S Gnanamanickam; Enwu Liu; Sarah N Hilmer; Maria Crotty Journal: Drugs Aging Date: 2018-01 Impact factor: 3.923
Authors: Zachary A Marcum; Megan E Amuan; Joseph T Hanlon; Sherrie L Aspinall; Steven M Handler; Christine M Ruby; Mary Jo V Pugh Journal: J Am Geriatr Soc Date: 2011-12-08 Impact factor: 5.562
Authors: Ian A Scott; Sarah N Hilmer; Emily Reeve; Kathleen Potter; David Le Couteur; Deborah Rigby; Danijela Gnjidic; Christopher B Del Mar; Elizabeth E Roughead; Amy Page; Jesse Jansen; Jennifer H Martin Journal: JAMA Intern Med Date: 2015-05 Impact factor: 21.873
Authors: Wade Thompson; Emily Reeve; Frank Moriarty; Malcolm Maclure; Justin Turner; Michael A Steinman; James Conklin; Lisa Dolovich; Lisa McCarthy; Barbara Farrell Journal: Res Social Adm Pharm Date: 2018-09-18
Authors: Elizabeth A Bayliss; Kathleen Albers; Kathy Gleason; Lisa E Pieper; Cynthia M Boyd; Noll L Campbell; Kristine E Ensrud; Shelly L Gray; Amy M Linsky; Derelie Mangin; Lillian Min; Michael W Rich; Michael A Steinman; Justin Turner; Eduard E Vasilevskis; Sascha Dublin Journal: J Am Geriatr Soc Date: 2022-06-01 Impact factor: 7.538
Authors: José Joaquín Mira; Irene Carrillo; Pastora Pérez-Pérez; Maria Pilar Astier-Peña; Johanna Caro-Mendivelso; Guadalupe Olivera; Carmen Silvestre; Mª Angeles Nuín; Jesús M Aranaz-Andrés Journal: J Patient Saf Date: 2021-12-01 Impact factor: 2.243